A
Apar Kishor Ganti
Researcher at University of Nebraska Medical Center
Publications - 276
Citations - 8034
Apar Kishor Ganti is an academic researcher from University of Nebraska Medical Center. The author has contributed to research in topics: Lung cancer & Cancer. The author has an hindex of 39, co-authored 241 publications receiving 6378 citations. Previous affiliations of Apar Kishor Ganti include United States Department of Veterans Affairs & University of North Dakota.
Papers
More filters
Journal ArticleDOI
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
Ezra E.W. Cohen,Denis Soulières,Christophe Le Tourneau,Christophe Le Tourneau,Christophe Le Tourneau,José Dinis,Lisa Licitra,Myung-Ju Ahn,Ainara Soria,Jean-Pascal Machiels,Jean-Pascal Machiels,Nicolas Mach,Ranee Mehra,Barbara Burtness,Pingye Zhang,Jonathan D. Cheng,Ramona F. Swaby,Kevin J. Harrington,Kevin J. Harrington,Mirelis Acosta-Rivera,Douglas Adkins,Morteza Aghmesheh,Mario Airoldi,Eduardas Aleknavicius,Yousuf Al-Farhat,Alain Algazi,Salah Almokadem,Anna Alyasova,Jessica Bauman,Marco Benasso,Alfonso Berrocal,Victoria Bray,Barbara Ann Burtness,F. Caponigro,Ana Castro,Terrence P. Cescon,Kelvin K. W. Chan,Arvind Chaudhry,Bruno Chauffert,Ezra W. Cohen,Tibor Csoszi,J. de Boer,Jean-Pierre Delord,Andreas Dietz,Charlotte Dupuis,Laurence Digue,Jozsef Erfan,Yolanda Alvarez,Mererid Evans,Mary J. Fidler,Martin David Forster,Signe Friesland,Apar Kishor Ganti,Lionnel Geoffrois,Cliona Grant,Viktor Gruenwald,Kevin J. Harrington,Thomas K. Hoffmann,Geza Horvai,Arturas Inciura,Raymond Woo-Jun Jang,Petra Jankowska,Antonio Jimeno,Mano Joseph,Alejandro Juarez Ramiro,Boguslawa Karaszewska,Andrzej Kawecki,Ulrich Keilholz,Ulrich Keller,Sung Bae Kim,Judit Kocsis,Nuria Kotecki,Mark F. Kozloff,Julio Lambea,Laszlo Landherr,Yuri Lantsukhay,Sergey Alexandrovich Lazarev,Lip Way Lee,Igor Dmitrievich Lifirenko,Danko Martincic,Oleg Vladmirovhich Matorin,Margaret McGrath,Krzysztof Misiukiewicz,John C. Morris,Fagim Fanisovich Mufazalov,Jiaxin Niu,Devraj Pamoorthy Srinivasan,Pedro Perez Segura,Daniel Rauch,Maria Leonor Ribeiro,Cristina P. Rodriguez,Frederic Rolland,Antonio Russo,Agnes Ruzsa,Frederico Sanches,Sang-Won Shin,Mikhail Shtiveland,Pol Specenier,Eva Szekanecz,Judit Szota,Carla M.L. van Herpen,Hector A. Velez-Cortes,William V. Walsh,Stefan Wilop,Ralph Winterhalder,Marek Z. Wojtukiewicz,Deborah Wong,Dan P. Zandberg +107 more
TL;DR: The clinically meaningful prolongation of overall survival and favourable safety profile of pembrolizumab in patients with recurrent or metastatic head and neck squamous cell carcinoma support the further evaluation of p embrolizUMab as a monotherapy and as part of combination therapy in earlier stages of disease.
Journal ArticleDOI
Targeting the EGFR signaling pathway in cancer therapy
Parthasarathy Seshacharyulu,Moorthy P. Ponnusamy,Dhanya Haridas,Maneesh Jain,Apar Kishor Ganti,Surinder K. Batra +5 more
TL;DR: A further understanding of the system is required to develop an effective anticancer regimen and a combination therapy that comprises an anti-EGFR and a chemotherapeutic/chemopreventive agent will exhibit a multi-pronged approach that can be developed into a highly attractive and specific molecular oriented remedy.
Journal ArticleDOI
Non-small cell lung cancer: Clinical practice guidelines in oncology
David S. Ettinger,Wallace Akerley,Gerold Bepler,Matthew G. Blum,Andrew C. Chang,Richard T. Cheney,Lucian R. Chirieac,Thomas A. D'Amico,Todd L. Demmy,Apar Kishor Ganti,Ramaswamy Govindan,Frederic W. Grannis,Thierry Jahan,Mohammad Jahanzeb,David H. Johnson,Anne Kessinger,Ritsuko Komaki,Feng Ming Kong,Mark G. Kris,Lee M. Krug,Quynh-Thu Le,Inga T. Lennes,Renato Martins,Janis P. O'Malley,Raymond U. Osarogiagbon,Gregory A. Otterson,Jyoti D. Patel,Katherine M.W. Pisters,Karen L. Reckamp,Gregory J. Riely,Eric M. Rohren,George R. Simon,Scott J. Swanson,Douglas E. Wood,Stephen C. Yang +34 more
TL;DR: The NCCN Clinical Practice Guidelines in Oncology for Small Cell Lung Cancer (SCLC) focus on extensive-stage SCLC because it occurs more frequently than limited-stage disease as discussed by the authors.
Journal ArticleDOI
Malignant pleural mesothelioma.
David S. Ettinger,Wallace Akerley,Hossein Borghaei,Andrew C. Chang,Richard T. Cheney,Lucian R. Chirieac,Thomas A. D'Amico,Todd L. Demmy,Apar Kishor Ganti,Ramaswamy Govindan,Frederic W. Grannis,Leora Horn,Thierry Jahan,Mohammad Jahanzeb,Anne Kessinger,Ritsuko Komaki,Feng Ming Kong,Mark G. Kris,Lee M. Krug,Inga T. Lennes,Billy W. Loo,Renato Martins,Janis P. O'Malley,Raymond U. Osarogiagbon,Gregory A. Otterson,Jyoti D. Patel,Mary Pinder-Schenck,Katherine M.W. Pisters,Karen L. Reckamp,Gregory J. Riely,Eric M. Rohren,Scott J. Swanson,Douglas E. Wood,Stephen C. Yang +33 more
TL;DR: These NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) focus on malignant pleural mesothelioma (MPM), which is the most common type.
Journal ArticleDOI
NCCN guidelines® insights: Small cell lung cancer, version 2.2018 featured updates to the NCCN guidelines
Gregory P. Kalemkerian,Billy W. Loo,Wallace Akerley,Albert Attia,Michael F. Bassetti,Yanis Boumber,Roy H. Decker,M. Chris Dobelbower,Afshin Dowlati,Robert J. Downey,Charles Florsheim,Apar Kishor Ganti,John C. Grecula,Matthew A. Gubens,Christine L. Hann,James A. Hayman,Rebecca S. Heist,Marianna Koczywas,Robert E. Merritt,Nisha Mohindra,Julian R. Molina,Cesar A. Moran,Daniel Morgensztern,Saraswati Pokharel,David C. Portnoy,Deborah J. Rhodes,Chad G. Rusthoven,Rafael Santana-Davila,Charles C. Williams,Karin G. Hoffmann,Miranda Hughes +30 more
TL;DR: The NCCN Guidelines for Small Cell Lung Cancer (SCLC) address all aspects of disease management regarding immunotherapy, systemic therapy, and radiation therapy and new sections were added on "Signs and Symptoms of SCLC" and "Principles of Pathologic Review."